A Timely Intervention: Early Clues to Identify the Patient with PsO at Risk of PsA

Program overview: This program is designed to educate dermatology practitioners to diagnose PsA early in their patients with psoriasis, to recognize the preclinical indicators of PsA risk, and to help guide clinical decisions based on the PsA risk profiles of their patients in order to treat psoriatic disease with therapies that cover the spectrum of psoriatic manifestations.

Host: Novartis

Location: Sheraton Denver, Grand Ballroom 1

Date: Saturday, March 21

Registration time: 6:30 p.m.

Program time: 7-8 p.m.

Register here.

Top